Company Filing History:
Years Active: 2014-2017
Title: Innovations by Elizabeth Masterjohn
Introduction
Elizabeth Masterjohn is an accomplished inventor based in Hudson, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to her name, her work focuses on addressing critical health issues.
Latest Patents
Her latest patents include "Nucleic acids encoding anti-CXCR3 antibodies" and "Anti-CXCR3 antibodies and methods of use thereof." These patents provide innovative solutions for diagnosing and treating CXCR3-associated disorders, such as diabetes mellitus type I (T1D), especially in cases of new-onset T1D. The disclosed CXCR3 neutralizing antibodies represent a promising advancement in therapeutic options for patients.
Career Highlights
Elizabeth Masterjohn is currently associated with Genzyme Corporation, where she continues to push the boundaries of medical research and innovation. Her work has the potential to significantly impact the treatment of autoimmune diseases.
Collaborations
She collaborates with talented professionals, including Michele Youd and Jennifer Tedstone, to further enhance her research and development efforts.
Conclusion
Elizabeth Masterjohn's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also offers hope for effective treatments for serious health conditions.